- Price
Supplier Type
- Manufacturer
- Trader
- Reagent
- custom synthesis
- contract manufacturer
Supplier Region
- Gujarat(41)
- Maharashtra(39)
- Tamil Nadu(2)
- Mumbai(66)
- New Delhi(6)
- Andhra Pradesh(2)
- Ahmedabad(18)
- Hyderabad(37)
- Delhi(13)
- Beijing(3)
- Bangalore(3)
- Telangana(2)
- Pune(6)
- Vadodara(8)
- Karnataka(7)
- Uttar Pradesh(7)
- Madhya Pradesh(1)
- Punjab(3)
- Haryana(3)
- Mallapur(1)
- Nagpur(2)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- MINIMUM 98%
- min 99.0%
- MIN 98%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99-100%
- 99.98%
- 99.97%
- 99.96%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.89%
- 99.86%
- 99.85%
- 99.82%
- 99.81%
- 99.73%
- 99.70%
- 99.52%
- ≥ 99.5%
- 99.5%
- 99.49%
- 99.45%
- 99.43%
- 99.42%
- 99.40%
- 99.29%
- 99.28%
- 99.27%
- 99.20%
- 99.0% MIN
- 99%
- >99%
- > 99%
- 99 % PURITY
- 99 %
- 98+
- 98.86%
- 98.81%
- 98.60%
- 98.20%
- 98.18%
- 98.12%
- 98.04%
- 98.00%
- 98%
- >98%
- 98 %
- 97-99%
- 97.76%
- 97.57%
- 97.00%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96.30%
- 96.00%
- 96%
- 95-99%
- 95-98%
- 95.00%
- 95%
- >95%
- 94.00%
- 93.21%
- >92%
- 91.41%
- 90%
- >90%
- 90 % Min.
- 90 % Above
- 48%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 15%
- 15
- 12%/15%
- 100% Pure
- 100%
- 100 %
- 1.0M
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 25mg
- 100mg
- 250mg
- 500mg
- 1gm
- 1000mg
- 25gm
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 50mg
- 1g
- 5g
- 10g
- 25g
- 50g
- 50gm
- 100g
- 100gm
- 100ml
- 200gm
- 250gm
- 500gm
- 500ml
- 500g
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1000kg
- 1and gm
- 1MT
- 3MT
- 50 gms
- 95NLT %
- 100 gms
- 500gms
- 250250 mg.
-
Ibrutinib Impurity 27
2031255-26-0
-
Ibrutinib Impurity 25
2052279-48-6
-
R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonamide
112101-81-2
-
Sodium bromide
7647-15-6
-
Platinum dioxide
1314-15-4
-
Ketoprofen
22071-15-4
-
Chlorobutanol
57-15-8
-
2-Chloromethyl-3-Methyl-4-Methoxypyridine
124473-12-7
-
6-Hydroxy-7-methoxy-3,4-dihydroquinazolin-4-one
179688-52-9
-
Acid blue 15
5863-46-7
Ethyleneglycol monoethyl ether acetate 111-15-9
Sodium bromide 7647-15-6
Carbon disulfide 75-15-0
Methyl 3-{[(2-Methoxy-2-oxoethyl)amino]sulfonyl}thiophene-2-carboxylate 106820-63-7
5-[(2R)-2-Aminopropyl]-2-methoxy benzene sulfonamide 112101-81-2
Carvedilol EP Impurity B 918903-20-5
meso-Tetrakis(o-pyridyl)porphine; Tetra-(2-pyridyl)-porphin; 5,10,15,20-Tetra-2-pyridylporphine; meso-Tetrakis(2-pyridyl)porphine; 5,10,15,20-tetra(2-pyridyl)porphyrin; meso-Tetra-2-pyridylporphine; meso-Tetra-(2-pyridyl)-porphyrin; 5,10,15,20-tetrakis(2-pyridyl)porphyrin; meso-Tetrakis(2-pyridyl)porphyrin; 5,10,15,20-tetra-pyridin-2-yl-21H,23H-porphine 40904-90-3
(R)-(-)-5-(2-Aminopropyl)-2- methoxy benzene sulfonamide 112101-81-2